Search - tctmd.com

Displaying 401 - 420 of 620

Sort: Relevancy | Date

Presentation TCT 2018

Acute Cardiogenic Shock: Pathophysiology and Treatment Goals

Presenter: Cindy L. Grines, E. Magnus Ohman, Timothy D. Henry

September 22, 2018

Presentation TCT 2018

Defining Cardiogenic Shock: Update From the SCAI/HFSA Working Group

Presenter: Cindy L. Grines, E. Magnus Ohman, David A Baran

September 22, 2018

Presentation TCT 2018

TCT-100: Emergency TAVR for Cardiogenic ShockRight Heart Function and Early Mechanical Circulatory Support Improve Outcomes

Presenter: Alain G. Cribier, Helene Eltchaninoff, Creighton Don

September 21, 2018

$TCT-84: Percuatenous Extracorporeal Membrane Oxygenation (ECMO) Utilization in Real World All Comers Population with Refractory Cardiac Arrest$

Presentation TCT 2018

TCT-84: Percuatenous Extracorporeal Membrane Oxygenation (ECMO) Utilization in Real World All Comers Population with Refractory Cardiac Arrest

Presenter: Biswajit Kar, Simon Redwood, Sachin Kumar

September 21, 2018

Presentation TCT 2018

TCT-83: Lactate and Cardiac Power Output Measurements at 12-24 Hours Reliably Predict Outcomes in Cardiogenic Shock: Insights from the National Cardiogenic Shock Initiative

Presenter: Biswajit Kar, Simon Redwood, Mir Basir

September 21, 2018

Presentation TCT 2018

TCT-82: Race-based Disparities in the Management and Outcomes of Cardiogenic Shock Complicating Acute Myocardial Infarction: A 15-Year National Study

Presenter: Biswajit Kar, Simon Redwood, Saraschandra Vallabhajosyula

September 21, 2018

Presentation TCT 2018

TCT-81: The Comparative Effectiveness and Safety of Impella Versus Intra-Aortic Balloon Pump in Patients who Underwent Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

Presenter: Biswajit Kar, Simon Redwood, Devraj Sukul

September 21, 2018

Presentation TCT 2018

Case #4: STEMI With Cardiogenic Shock

Presenter: Ajay J. Kirtane, Yuejin Yang, Ziad A. Ali, George D. Dangas, Lei Ge, J. Aaron Grantham, Ning Guo, Gary S. Mintz

September 21, 2018

Presentation TCT 2018

TCT-24: Impact of Bleeding on Outcome and Predictive Value of Bleeding Scores in Patients With Cardiogenic Shock - a Substudy of the CULPRIT-SHOCK trial

Presenter: Angeles Alonso Garcia, Rajesh M. Dave, Anne Freund

September 21, 2018

Presentation TCT 2018

Interventional Management of Cardiogenic Shock: Clinical Indications and Therapeutic Options

Presenter: William W. O'Neill

September 21, 2018

Presentation TCT 2018

Revascularization in Cardiogenic Shock: New Insights

Presenter: Jeroen J. Bax, Stephan Windecker, Holger Thiele

September 21, 2018

News Opinion Editor's Corner TCT 2017

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Shelley Wood

November 22, 2017

News Conference News TCT 2017

Massive Study Offers Snapshot of PCI Outcomes in Nonagenarians

Ashley Lyles

November 06, 2017

Presentation TCT 2017

ECMO for Cardiogenic Shock Who, When, Where

Presenter: Ulrich P. Jorde, Michael Mooney, Hiroo Takayama, Jiri Maly

November 01, 2017

Presentation TCT 2017

Topic 4: Advanced Hemodynamic Support Devices Improve Survival and Outcomes in Cardiogenic Shock, Justifying Their Use CON!

Presenter: Nick Curzen, Fausto Feres, Simon Redwood

November 01, 2017

Presentation TCT 2017

Topic 4: Advanced Hemodynamic Support Devices Improve Survival and Outcomes in Cardiogenic Shock, Justifying Their Use PRO!

Presenter: Nick Curzen, Fausto Feres, Robert F. Riley

November 01, 2017

Presentation TCT 2017

Acute Kidney Injury in Cardiogenic Shock: Impact of Hemodynamic Support

Presenter: Somjot S. Brar, Roxana Mehran, Michael P. Flaherty

November 01, 2017

Presentation TCT 2017

Flash Debate: Registry Data and Personal Experiences Are Strong Enough to Justify Frequent Use of IMPELLA in High-Risk PCI and Cardiogenic Shock!

Presenter: Sanjay Kaul, Tullio Palmerini, Dimitri Karmpaliotis

November 01, 2017

Presentation TCT 2017

Flash Debate: There Is Insufficient Evidence From Randomized Trials to Justify Frequent Use of Impella in High-Risk PCI and Cardiogenic Shock!

Presenter: Sanjay Kaul, Tullio Palmerini, Holger Thiele

November 01, 2017

Presentation TCT 2017

Case Report From Algeria: Primary PCI With Cardiogenic Shock in a Young Patient

Presenter: Mohamed Abed Bouraghda, Bashir Hanif, Said Benghezel

November 01, 2017

Advertisement

Acute Cardiogenic Shock: Pathophysiology and Treatment Goals

Defining Cardiogenic Shock: Update From the SCAI/HFSA Working Group

TCT-100: Emergency TAVR for Cardiogenic ShockRight Heart Function and Early Mechanical Circulatory Support Improve Outcomes

TCT-84: Percuatenous Extracorporeal Membrane Oxygenation (ECMO) Utilization in Real World All Comers Population with Refractory Cardiac Arrest

TCT-83: Lactate and Cardiac Power Output Measurements at 12-24 Hours Reliably Predict Outcomes in Cardiogenic Shock: Insights from the National Cardiogenic Shock Initiative

TCT-82: Race-based Disparities in the Management and Outcomes of Cardiogenic Shock Complicating Acute Myocardial Infarction: A 15-Year National Study

TCT-81: The Comparative Effectiveness and Safety of Impella Versus Intra-Aortic Balloon Pump in Patients who Underwent Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

Case #4: STEMI With Cardiogenic Shock

TCT-24: Impact of Bleeding on Outcome and Predictive Value of Bleeding Scores in Patients With Cardiogenic Shock - a Substudy of the CULPRIT-SHOCK trial

Interventional Management of Cardiogenic Shock: Clinical Indications and Therapeutic Options

Revascularization in Cardiogenic Shock: New Insights

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Massive Study Offers Snapshot of PCI Outcomes in Nonagenarians

ECMO for Cardiogenic Shock Who, When, Where

Topic 4: Advanced Hemodynamic Support Devices Improve Survival and Outcomes in Cardiogenic Shock, Justifying Their Use CON!

Topic 4: Advanced Hemodynamic Support Devices Improve Survival and Outcomes in Cardiogenic Shock, Justifying Their Use PRO!

Acute Kidney Injury in Cardiogenic Shock: Impact of Hemodynamic Support

Flash Debate: Registry Data and Personal Experiences Are Strong Enough to Justify Frequent Use of IMPELLA in High-Risk PCI and Cardiogenic Shock!

Flash Debate: There Is Insufficient Evidence From Randomized Trials to Justify Frequent Use of Impella in High-Risk PCI and Cardiogenic Shock!

Case Report From Algeria: Primary PCI With Cardiogenic Shock in a Young Patient

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content